Plain-English translation of NCT02704520 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The TRIGGER trial is testing whether a detailed MRI scan taken after radiation therapy can help doctors personalize treatment for rectal cancer. Instead of all patients having surgery, this trial aims to identify patients whose tumors have responded very well to radiation—and may safely avoid surgery while maintaining quality of life. For patients whose tumors haven't responded as well, doctors will use that information to plan more intensive treatment.
Rectal cancer surgery can seriously affect quality of life, causing permanent changes to bowel and sexual function. This trial exists to find out whether we can safely spare some patients from surgery by using better imaging to predict who will do well without it, while making sure patients with aggressive tumors get the extra treatment they need.
You likely qualify if…
You likely don't qualify if…
You will receive standard radiation therapy (with or without chemotherapy) as planned by your doctors. After treatment ends, you'll have an MRI scan to measure how your tumor has responded. Based on your scan results, your medical team will either suggest watching and waiting without immediate surgery, or discuss additional treatment options. The trial tracks your health and outcomes over time to see if this MRI-guided approach works better than standard care.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United Kingdom